<PAGE>
UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058
WASHINGTON, D.C. 20549 Expires: May 31, 1997
Estimated average burden
FORM 12b-25 hours per response 2.50
SEC FILE NUMBER
0-13849
(Check One): [X] Form 10-K [ ] Form 20-F
[ ] Form 11-K [ ] Form 10-Q
[ ] Form N-SAR CUSIP NUMBER
751582206
---------------------
For Period Ending: June 30, 1996
------------------------------------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: -----------------------------
- --------------------------------------------------------------------------------
Read Instruction (on back page) Before Preparing form.
Please Print or type.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION
HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.
- --------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
- --------------------------------------------------------------------------------
PART I -- REGISTRANT INFORMATION
Ramsay Health Care, Inc.
- --------------------------------------------------------------------------------
Full Name of Registrant
N/A
- --------------------------------------------------------------------------------
Former Name if Applicable
Entergy Corporation Building, 639 Loyola Avenue, Suite 1700
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
New Orleans, Louisiana 70113
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II -- RULES 12B-25(B) AND (C)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
|X| (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will
be filed on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly report of transition
report on form 10-Q, or portion thereof will be filed on or before
the fifth calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-
25(c) has been attached if applicable.
PART III -- NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
See Exhibit A attached hereto
(ATTACH EXTRA SHEETS IF NEEDED)
SEC 1344 (6/94)
<PAGE>
PART IV -- OTHER INFORMATION
<TABLE>
<CAPTION>
(1) Name and telephone number of person to contact in regard to this notification
<S> <C> <C>
Bradley P. Cost, Esq. 212 880-6000
- ------------------------------------------------------------ ------------------------ -----------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities
Exchange Act of 1934 or Section 30 of the investment Company Act of 1940 during the preceding 12
months or for such shorter period that the registrant was required to file such report(s) been
filed? If answer is no, identify report(s). [X] Yes [ ] No
- ----------------------------------------------------------------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings statements to be
included in the subject report or portion thereof? [X] Yes [ ] No
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
</TABLE>
See Exhibit B attached hereto
---------------------------------------------------------------------------
Ramsay Health Care, Inc.
------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date September 30, 1996 By /s/Remberto Cibran
------------------------------ ---------------------------------
Remberto Cibran, President
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
ATTENTION
- --------------------------------------------------------------------------------
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
- --------------------------------------------------------------------------------
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General rules
and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange
Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
General Rules and Regulations under the Act. The information contained in or
filed with the form will be made a matter of public record in the Commission
files.
3. A manually signed copy of the form and amendments thereto shall be filed with
each national securities exchange on which any class of securities of the
registrant is registered.
4. Amendments to the notifications must also be filed on form 12b-25 but need
not restate information that has been correctly furnished. The form shall be
clearly identified as an amended notification.
5. Electronic Files. This form shall not be used by electronic filers unable to
timely file a report solely due to electronic difficulties. Filers unable to
submit a report within the time period prescribed due to difficulties in
electronic filing should comply with either Rule 201 or Rule 202 of
Regulation S-T ((S) 232.201 or (S) 232.202 of this chapter) or apply for an
adjustment in filing date pursuant to Rule 13(b) of Regulation S-T ((S)
232.13(b) of this chapter).
<PAGE>
Ramsay Health Care, Inc.
Exhibit A to Form 12b-25
As a result of unforeseen delays in connection with the
preparation of the registrant's year-end financial statements, the
registrant is unable to file its Annual Report on Form 10-K within the
prescribed time period. The registrant cannot eliminate the reasons
for its inability to file the forgoing Report without unreasonable
effort and/or expense. The foregoing Report will be filed no later
than the fifteenth calendar day following the prescribed due date for
the Report.
<PAGE>
Ramsay Health Care, Inc.
Exhibit B to Form 12b-25
The registrant anticipates that it will report a change in
its results of operations for the annual period ended June 30, 1996
from the corresponding period for the last fiscal year. The
registrant expects to report a net loss of ($16,481,000) for the
fiscal year ended June 30, 1996. This compares to a net loss of
($17,302,000) for the registrant's last fiscal year.
